Retatrutide Revion

Retatrutide Revion Pen refers to an investigational, injectable medication for weight loss, a triple-agonist targeting GIP, GLP-1, and glucagon receptors, showing significant weight reduction in trials by reducing appetite and increasing metabolism, available in pre-filled pens for weekly subcutaneous use, though still under development and not yet FDA-approved for general use. Suppliers in India offer it in pen form for research/export, often citing 12mg strength pens with potential doses up to 60mg or more, mimicking similar drugs like Ozempic but with a triple-hormone approach for potentially greater efficacy.